Serum Institute of India (SII)
SII to launch vax for kids in 6 mnths
ndia is yet to start vaccinating children below 18, who form 40 per cent of the country’s population
Serum Institute plans to launch Novavax shot for children in six months
The Novavax shot has shown good results in trials in children aged three and older, said Adar Poonawalla
No recommendations for COVID-19 booster dose by SEC: Sources
Amid the emergence of the new COVID variant Omicron, the SII had sought approval to administer the booster dose of its Covishield vaccine
India allows Serum Institute to enrol 7-11 year olds in Novavax Covid vaccine trial
Serum Institute is already conducting a trial of its COVID-19 vaccine Covovax
UK adds Covishield to approved vaccines list in updated travel advisory
The move follows widespread condemnation of the SII-manufactured vaccines not being included in a list of eligible vaccines
CII-Serum Institute to work to expand vaccination across small towns, rural areas
CII undertook a survey with responses from over 3,000 companies in 196 cities
Sputnik V to be produced at SII from September, says RDIF
India is the leading production hub for the production of the Sputnik vaccine
Govt panel refuses SII permission to conduct Phase 2, 3 trials of Covavax on children
SII had applied to the DCGI seeking permission to conduct clinical trials of Covavax on children at 10 sites
Serum Institute asks govt to take up inclusion of Covishield in vaccination passport with EU
Poonawalla in his letter is learnt to have mentioned that nearly 30 crore people have already been vaccinated with Covishield in India
WHO reminds Serum Institute of its COVAX commitments amidst soaring demand in India
Earlier this month, Adar Poonawalla said it was not possible to ramp up production overnight